This resembles putative loss- and gain-of-function pathophysiology that is attributed to Nav1.7 channelopathies (Dib-Hajj et al., 2005; Cox et al., 2006; Faber et al., 2012; Bennett et al., 2019; McDermott et al., 2019). This evidence concerns the gene SCN9A and channelopathy.